US WorldMeds reports initial results from phase III clinical trial of lofexidine June 19, 2008 No Comments
Novartis launches oral iron-chelating agent Exjade for chronic iron overload in Japan June 16, 2008 No Comments
Targacept designates neuronal nicotinic receptor drug in smoking cessation program May 7, 2008 No Comments
DOR BioPharma initiates nonhuman primate efficacy studies of RiVax ricin toxin vaccine May 2, 2008 No Comments
Independent Pharmaceutica initiates phase II clinical trial of Niccine for nicotine dependence April 30, 2008 No Comments
Department of Defense awards contract to Cleveland BioLabs to develop Protectan April 8, 2008 No Comments